Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOVES-PD phase 2 trial of venglustat versus placebo in early GBA-associated Parkinson's disease
MOH_2017-12-13_000511Phase 2Completed
- Sponsor
- Sanofi
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Parkinson's disease (PD) comparing Placebo with Venglustat (2 arms). Primary endpoint: Primary endpoint not reported. Started Aug 2017; status: completed.
02
Drugs
venglustat
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on MOH_2017-12-13_000511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2017-12-13_000511.